Vyndaqel Capsules 20mg, manufactured by Pfizer, contain Tafamidis meglumine at a standard dosage of 20mg per capsule, with YJ code 1290001M1022. It is indicated for the treatment of transthyretin-mediated amyloidosis with cardiomyopathy.
Vyndaqel Capsules 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →